Pharmacotherapy to Enhance Cognitive and Motor Recovery Following Stroke

作者: Xabier Beristain , Esteban Golombievski

DOI: 10.1007/S40266-015-0299-0

关键词:

摘要: Stroke is a leading cause of disability among older adults and more than half stroke survivors have some residual neurological impairment. Traditionally, managing the aftermath has been by implementation several physical language therapy modalities. The limitations these rehabilitation efforts sparked an interest in finding other ways to enhance recovery. Some novel approaches included pharmacological interventions, cell-derived treatments, cortical magnetic stimulation. Mounting evidence over last 2 decades suggests that manipulations may potential modulate practice-dependent neuroplasticity potentially improve recovery after stroke. Multiple agents with different mechanisms action evaluated, showing conflicting results. studies suggest promise, yet quality available suboptimal overall, most being underpowered. So far, promising include antidepressants for motor acetylcholinesterase inhibitors memantine aphasia. However, large, well-designed clinical trials are needed address shortcomings data before any agent can be recommended routine use as part standard algorithm management.

参考文章(56)
Paolucci S, Role, indications, and controversies of antidepressant therapy in chronic stroke patients. European Journal of Physical and Rehabilitation Medicine. ,vol. 49, pp. 233- 241 ,(2013)
Paolo Manganotti, Michele Acler, Role, indications and controversies of levodopa administration in chronic stroke patients. European Journal of Physical and Rehabilitation Medicine. ,vol. 49, pp. 243- 249 ,(2013)
D Walker-Batson, Amphetamine and post-stroke rehabilitation: indications and controversies. European Journal of Physical and Rehabilitation Medicine. ,vol. 49, pp. 251- 260 ,(2013)
Louise Martinsson, Staffan Eksborg, Drugs for stroke recovery: the example of amphetamines. Drugs & Aging. ,vol. 21, pp. 67- 79 ,(2004) , 10.2165/00002512-200421020-00001
Amara Larpthaveesarp, Donna Ferriero, Fernando Gonzalez, Growth factors for the treatment of ischemic brain injury (growth factor treatment). Brain Sciences. ,vol. 5, pp. 165- 177 ,(2015) , 10.3390/BRAINSCI5020165
Caterina Breitenstein, Catharina Korsukewitz, Annette Baumgärtner, Agnes Flöel, Pienie Zwitserlood, Christian Dobel, Stefan Knecht, L-dopa does not add to the success of high-intensity language training in aphasia. Restorative Neurology and Neuroscience. ,vol. 33, pp. 115- 120 ,(2015) , 10.3233/RNN-140435
Jacqueline Birks, Bernadette McGuinness, David Craig, Rivastigmine for vascular cognitive impairment Cochrane Database of Systematic Reviews. ,(2013) , 10.1002/14651858.CD004744.PUB3
Klaus Scheidtmann, Advances in adjuvant pharmacotherapy for motor rehabilitation: effects of levodopa. Restorative Neurology and Neuroscience. ,vol. 22, pp. 393- 398 ,(2004)
Nina Rösser, Agnes Flöel, Pharmacological enhancement of motor recovery in subacute and chronic stroke. NeuroRehabilitation. ,vol. 23, pp. 95- 103 ,(2008) , 10.3233/NRE-2008-23110